Additional Relevant Details CMB305 is a prime-boost approach in which LV305 is dosed sequentially with G305 to induce a synergistic anti-tumor cytotoxic T lymphocyte (CTL) response. CMB305 may also generate memory CTLs, and therefore long-term immune surveillance, as well as enhance other immune anti-tumor mechanisms.